India's largest biopharmaceutical company, headquartered in Bengaluru, developing and manufacturing biosimilars (insulins, trastuzumab, bevacizumab, pegfilgrastim), complex generics and APIs for global markets, with a major manufacturing campus in Biocon Special Economic Zone.
Aucun commentaire disponible.
Laissez votre note & commentaire